文献速递新生儿儿童血液肿瘤与免疫

新生儿血小板减少症:血小板输注后计数增量的相关因素

Neonatal Thrombocytopenia: Factors Associated With the Platelet Count Increment Following Platelet Transfusion.
PubMed 文献 · J Pediatr · 2023-08-11

该研究回顾性分析了8个新生儿重症监护中心6年内的1797次血小板输注(605名新生儿),发现输注后血小板计数增量与出生胎龄、输注日龄、供者性别或年龄无关;增量在消耗性血小板减少症、病原体灭活处理、较长血小板保存时间及ABO血型不合时较低。

要点

  • 新生儿血小板输注后增量不受出生胎龄、输注日龄、供者性别或年龄影响。
  • 消耗性血小板减少症、病原体灭活、较长保存时间及ABO不合时增量较低。
  • 严重血小板减少症(<20 000/μL)患儿中,增量不良和死亡与病因相关。

核心结论

  • 新生儿血小板输注后血小板计数增量不受多数研究变量影响,但在消耗性血小板减少症、病原体灭活处理、较长血小板保存时间及ABO血型不合时增量较低。

研究设计与样本

  • 回顾性研究,纳入8个新生儿中心6年内605名新生儿接受的1797次血小板输注,中位每受者1次,均值3次,范围1-52次。

主要发现

  • 输注后增量与出生胎龄、输注日龄、供者性别或年龄无关。
  • 消耗性血小板减少症较生成减少性增量略低(P < .001)。
  • 病原体灭活处理后增量略低(P < .01)。
  • 血小板保存时间较长时增量略低(P < .001)。
  • O型新生儿接受非O型供者血小板时增量略低(P < .001)。

临床怎么用

  • 新生儿血小板输注后评估增量时需考虑血小板减少病因、是否病原体灭活、保存时间及ABO血型匹配情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To understand better those factors relevant to the increment of rise in platelet count following a platelet transfusion among thrombocytopenic neonates. STUDY DESIGN: We reviewed all platelet transfusions over 6 years in our multi-neonatal intensive care unit system. For every platelet transfusion in 8 neonatal centers we recorded: (1) platelet count before and after transfusion; (2) time between completing the transfusion and follow-up count; (3) transfusion volume (mL/kg); (4) platelet storage time; (5) sex and age of platelet donor; (6) gestational age at birth and postnatal age at transfusion; and magnitude of rise as related to (7) pre-transfusion platelet count, (8) method of enhancing transfusion safety (irradiation vs pathogen reduction), (9) cause of thrombocytopenia, and (10) donor/recipient ABO group. RESULTS: We evaluated 1797 platelet transfusions administered to 605 neonates (median one/recipient, mean 3, and range 1-52). The increment was not associated with gestational age at birth, postnatal age at transfusion, or donor sex or age. The rise was marginally lower: (1) with consumptive vs hypoproductive thrombocytopenia (P < .001); (2) after pathogen reduction (P < .01); (3) after transfusing platelets with a longer storage time (P < .001); and (4) among group O neonates receiving platelets from non-group O donors (P < .001). Eighty-seven neonates had severe thrombocytopenia (<20 000/μL). Among these infants, poor increments and death were associated with the cause of the thrombocytopenia. CONCLUSION: The magnitude of post-transfusion rise was unaffected by most variables we studied. However, the increment was lower in neonates with consumptive thrombocytopenia, after pathogen reduction, with longer platelet storage times, and when not ABO matched.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Christensen RD, Bahr TM, Davenport P, et al. Neonatal Thrombocytopenia: Factors Associated With the Platelet Count Increment Following Platelet Transfusion. J Pediatr. 2023. PMID: 37572863. doi:10.1016/j.jpeds.2023.113666

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。